istiratumab

Ligand id: 8930

Name: istiratumab

Classification
Compound class Antibody
International Nonproprietary Names
INN number INN
10431 istiratumab
Synonyms
MM-141 | MM141
Comments
Istiratumab (MM-141) is a fully human bispecific monoclonal antibody co-targeting the IGF-I receptor (IGF-IR) and epidermal growth factor receptor ERBB3 that was developed by Merrimack Pharmaceuticals to block tumour survival signals [1,3,5].
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record.
Database Links
Specialist databases
IMGT/mAb-DB 545
Other databases
GtoPdb PubChem SID 310264711
Search PubMed clinical trials istiratumab
Search PubMed titles istiratumab
Search PubMed titles/abstracts istiratumab